Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study.

Lytvyn, Y; Georgakopoulos, J R; Mufti, A; Devani, A R; Gooderham, M J; Jain, V; Lansang, P; Vender, R; Prajapati, V H; Yeung, J

Lytvyn, Y; Georgakopoulos, J R; Mufti, A; Devani, A R; Gooderham, M J; Jain, V; Lansang, P; Vender, R; Prajapati, V H; Yeung, J.

Lytvyn Y; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
Devani AR; Dermatology Research Institute, Calgary, AB, Canada.
Gooderham MJ; Skin Health & Wellness Centre, Calgary, AB, Canada.
Jain V; Probity Medical Research, Calgary, AB, Canada.
Lansang P; Queen's University, Kingston, ON, Canada.
Vender R; SKiN Centre for Dermatology, Peterborough, ON, Canada.
Prajapati VH; Probity Medical Research, Peterborough, ON, Canada.
Yeung J; Clinal Immunology and Allergy, McMaster University, Hamilton, ON, Canada.

J Eur Acad Dermatol Venereol ; 36(2): e94-e95, 2022 Feb.

Article in English | MEDLINE | ID: covidwho-1570801

Subject(s)

COVID-19; Psoriasis; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Humans; Incidence; Prognosis; Psoriasis/drug therapy; Psoriasis/epidemiology; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thalidomide/analogs & derivatives

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.17749

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google